McKesson Aktie

0.00 CHF 0.00CHF 0.00%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
The Vanguard Group, Inc. 8.59
BlackRock Fund Advisors 5.16
SSgA Funds Management, Inc. 4.87
Wellington Management Co. LLP 4.23
Massachusetts Financial Services Co. 3.14
Glenview Capital Management LLC 2.64
Boston Partners Global Investors, Inc. 2.41
Invesco Advisers, Inc. 2.35
Vulcan Value Partners LLC 2.26
Pzena Investment Management LLC 2.07
Fidelity Management & Research Co. 2.00
Nordea Investment Management AB (Denmark) 1.76
AQR Capital Management LLC 1.57
The Baupost Group LLC 1.39
CI Investments, Inc. 1.36

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018 2019
Personal am Ende des Jahres 42'800 70'400 68'000 78'000 78'000 80'000
Umsatz pro Mitarbeiter in Mio. EUR 3.22 2.54 2.81 2.55 2.67 2.68

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018 2019
Summe Umlaufvermögen 32'573 36'670 38'437 36'948 37'136 38'465
Summe Anlagevermögen 19'241 17'845 17'078 19'640 17'684 15'689
Summe Aktiva 51'759 53'870 56'563 60'969 60'381 59'672

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 10'719 9'844 8'154 8'545 7'880 7'595
Summe Fremdkapital 41'441 44'399 46'149 48'369 48'865 49'992
Summe Eigenkapital 10'318 9'471 10'414 12'600 11'516 9'680
Summe Passiva 51'759 53'870 56'563 60'969 60'381 59'672

Adresse

6555 State Highway 161, 75039 Irving
Telefon 19724464800
Internet http://www.mckesson.com

Management

April Marks
Public Relations & Media Contact
Bansi Nagji, MBA
Chief Strategy & Business Development Officer, EVP
Bradley E. Lerman
Independent Director
Brian P. Moore, CFA
Treasurer & Senior Vice President
Brian Scott Tyler, PhD
Chief Executive Officer & Director
Britt Vitalone, CPA
Chief Financial Officer & Executive Vice President
Craig Mercer
Senior Vice President-Investor Relations
Dominic J. Caruso
Independent Director
Donald R. Knauss
Independent Director
Edward A. Mueller, MBA
Chairman
Jorge L. Figueredo, MBA
Chief Human Resources Officer & EVP
Kathleen D. McElligott, MBA
Chief Technology & Information Officer, EVP
Kenneth E. Washington, PhD
Independent Director
Kirk Kaminsky
President-US Pharmaceutical & Specialty Solutions
Kristin Chasen
General & Business Media Contact
Lori A. Schechter
Chief Compliance Officer, EVP & General Counsel
M. Christine Jacobs
Independent Director
Marie L. Knowles, MBA
Independent Director
Michele Lau
Secretary & Senior Vice President
N. Anthony Coles Jr., MD
Independent Director
Nathan Mott
President-Prescription Technology Solutions
Sundeep Reddy MBA, CPA
Chief Accounting Officer, SVP & Controller
Susan R. Salka
Independent Director

Eintrag hinzufügen